Immunomedics Reports Second Quarter 2019 Results and Provides Corporate Update

    NEXT STORY
    Radius Health Announces Second Quarter 2019 Operating Results
    PREV STORY
    Hepion Pharmaceuticals Welcomes Dr. Stephen Harrison to its Scientific Advisory Board
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    QTERN (saxa/dapa) EU approved for type-2 diabetes

    This announcement contains inside information 19 July 2016 14:15 ASTRAZENECA RECEIVES APPROVAL IN THE ...

    author_avatar
    NASDAQ Market News

    Vir Biotechnology to Provide Corporate Update and Report First Quarter 2021 Financial Results on May 6, 2021

    author_avatar
    NASDAQ Market News

    Ziopharm Oncology Scientific Advisor Laurence Cooper, MD, PhD, to Present at University of Pennsylvania Cellicon Valley ’21 Two-Day Live Virtual Educational Symposium

    author_avatar
    NASDAQ Market News